Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of $26.34 billion. The enterprise value is $28.12 billion.
| Market Cap | 26.34B |
| Enterprise Value | 28.12B |
Important Dates
The last earnings date was Tuesday, July 28, 2026, before market open.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | Aug 27, 2026 |
Share Statistics
Xylem has 233.49 million shares outstanding. The number of shares has decreased by -0.70% in one year.
| Current Share Class | 233.49M |
| Shares Outstanding | 233.49M |
| Shares Change (YoY) | -0.70% |
| Shares Change (QoQ) | -2.79% |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 95.91% |
| Float | 232.88M |
Valuation Ratios
The trailing PE ratio is 26.84 and the forward PE ratio is 19.18. Xylem's PEG ratio is 1.60.
| PE Ratio | 26.84 |
| Forward PE | 19.18 |
| PS Ratio | 2.89 |
| Forward PS | 2.81 |
| PB Ratio | 2.53 |
| P/TBV Ratio | 1,755.98 |
| P/FCF Ratio | 27.49 |
| P/OCF Ratio | 20.25 |
| PEG Ratio | 1.60 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.22, with an EV/FCF ratio of 29.35.
| EV / Earnings | 27.62 |
| EV / Sales | 3.08 |
| EV / EBITDA | 14.22 |
| EV / EBIT | 19.90 |
| EV / FCF | 29.35 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.61 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | 3.19 |
| Interest Coverage | 61.43 |
Financial Efficiency
Return on equity (ROE) is 9.18% and return on invested capital (ROIC) is 8.99%.
| Return on Equity (ROE) | 9.18% |
| Return on Assets (ROA) | 5.11% |
| Return on Invested Capital (ROIC) | 8.99% |
| Return on Capital Employed (ROCE) | 9.67% |
| Weighted Average Cost of Capital (WACC) | 8.85% |
| Revenue Per Employee | $414,818 |
| Profits Per Employee | $46,273 |
| Employee Count | 22,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 5.31 |
Taxes
In the past 12 months, Xylem has paid $264.00 million in taxes.
| Income Tax | 264.00M |
| Effective Tax Rate | 20.74% |
Stock Price Statistics
The stock price has decreased by -21.52% in the last 52 weeks. The beta is 1.01, so Xylem's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -21.52% |
| 50-Day Moving Average | 117.95 |
| 200-Day Moving Average | 125.79 |
| Relative Strength Index (RSI) | 38.91 |
| Average Volume (20 Days) | 1,670,915 |
Short Selling Information
The latest short interest is 7.73 million, so 3.31% of the outstanding shares have been sold short.
| Short Interest | 7.73M |
| Short Previous Month | 7.88M |
| Short % of Shares Out | 3.31% |
| Short % of Float | 3.32% |
| Short Ratio (days to cover) | 3.77 |
Income Statement
In the last 12 months, Xylem had revenue of $9.13 billion and earned $1.02 billion in profits. Earnings per share was $4.20.
| Revenue | 9.13B |
| Gross Profit | 3.58B |
| Operating Income | 1.41B |
| Pretax Income | 1.27B |
| Net Income | 1.02B |
| EBITDA | 1.98B |
| EBIT | 1.41B |
| Earnings Per Share (EPS) | $4.20 |
Balance Sheet
The company has $1.28 billion in cash and $3.06 billion in debt, with a net cash position of -$1.78 billion or -$7.62 per share.
| Cash & Cash Equivalents | 1.28B |
| Total Debt | 3.06B |
| Net Cash | -1.78B |
| Net Cash Per Share | -$7.62 |
| Equity (Book Value) | 10.67B |
| Book Value Per Share | 44.63 |
| Working Capital | 1.67B |
Cash Flow
In the last 12 months, operating cash flow was $1.30 billion and capital expenditures -$343.00 million, giving a free cash flow of $958.00 million.
| Operating Cash Flow | 1.30B |
| Capital Expenditures | -343.00M |
| Depreciation & Amortization | 565.00M |
| Net Borrowing | 927.00M |
| Free Cash Flow | 958.00M |
| FCF Per Share | $4.10 |
Margins
Gross margin is 39.24%, with operating and profit margins of 15.48% and 11.15%.
| Gross Margin | 39.24% |
| Operating Margin | 15.48% |
| Pretax Margin | 13.95% |
| Profit Margin | 11.15% |
| EBITDA Margin | 21.67% |
| EBIT Margin | 15.48% |
| FCF Margin | 10.50% |
Dividends & Yields
This stock pays an annual dividend of $1.72, which amounts to a dividend yield of 1.53%.
| Dividend Per Share | $1.72 |
| Dividend Yield | 1.53% |
| Dividend Growth (YoY) | 8.33% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 40.92% |
| Buyback Yield | 0.70% |
| Shareholder Yield | 2.23% |
| Earnings Yield | 3.86% |
| FCF Yield | 3.64% |
Analyst Forecast
The average price target for Xylem is $153.88, which is 36.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $153.88 |
| Price Target Difference | 36.41% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (3Y) | 3.91% |
| EPS Growth Forecast (3Y) | 10.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Xylem has an Altman Z-Score of 4.12 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.12 |
| Piotroski F-Score | 5 |